Alternative Communication and Brain-Computer Interface Synergy

Alternative Communication and Brain-Computer Interface Synergy
Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

On this page8 sections

Article Summary

The National Institute on Deafness and Other Communication Disorders (NIDCD), one of the National Institutes of Health (NIH), held a programmatic workshop, Towards AAC-BCI Synergy, on September 17, 2015. The intent was to explore ways to move towards synergy between the Augmentative and Alternative Communication (AAC) and the Brain-Computer Interface (BCI) research fields. The virtual workshop used the WebEx platform to connect presenters and participants....

Key Takeaways

  • This article explains Background in simple medical language.
  • This article explains Participants in simple medical language.
  • This article explains Pre-Workshop Discussion in simple medical language.
  • This article explains Workshop Format in simple medical language.
Before reading

RX Patient Tools

Use these quick guides before reading the article, or return to them when you need help preparing questions for a doctor.

Start here Choose the right pathway for symptoms, reports, medicines, or urgent warning signs. Disease article roadmap Read this topic step by step: meaning, symptoms, warning signs, diagnosis, treatment, prevention, and follow-up. Treatment planner Prepare questions about treatment choices, benefits, risks, side effects, and follow-up. Family & caregiver guide Organize symptoms, reports, medicines, questions, and follow-up safely. Nutrition & diet guide Prepare food, hydration, supplement, and medicine-timing questions safely. Prevention guide Organize risk factors, protective habits, screening, and warning signs. Recovery guide Prepare a safe plan for activity, rehabilitation, warning signs, and follow-up.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.
Definition

The National Institute on Deafness and Other Communication Disorders (NIDCD), one of the National Institutes of Health (NIH), held a programmatic workshop, Towards AAC-BCI Synergy, on September 17, 2015. The intent was to explore ways to move towards synergy between the Augmentative and Alternative Communication (AAC) and the Brain-Computer Interface (BCI) research fields. The virtual workshop used the WebEx platform to connect presenters and participants. Scot Ryder of the NIDCD Information Systems Management Branch (ISMB) served as the WebEx resource staff member.

Background

The NIDCD held its first workshop on AAC in 1994. With recent advances in BCI development, the NIDCD held a workshop in 2006 on AAC-BCI, focusing on BCI for speech synthesis. Despite growth in the NIDCD voice and speech research portfolio, there was a need to foster better collaboration across the fields of AAC and BCI and to work towards synergy between them.

Participants

The concept for the workshop emerged from professional discussions between Roger Miller, Ph.D., and Lana Shekim, Ph.D., of the NIDCD Division of Scientific Programs (DSP). They organized the workshop in consultation with Melanie Fried-Oken, Ph.D., of the Oregon Health and Science University, and  Richard Ellenson, CEO of International Research Foundation (CPIRF). Drs. Fried-Oken and Shekim co-chaired the workshop.

Pre-Workshop Discussion

The need for such a workshop became apparent to Drs. Miller and Shekim after they attended the 5th International BCI meeting, held in Asilomar, California, in 2013. In preparation for this workshop, Dr. Shekim visited the laboratory of Dr. Fried-Oken in Portland, Oregon, in May 2015. There she experienced their BCI system and met with potential users of the system (individuals with speech and physical impairments, or SSPI, and their caregivers). Dr. Fried-Oken, Dr. Shekim, and Dr. Miller further refined the plans for the workshop in consultation with Mr. Ellenson of CPIRF.

Workshop Format

The online workshop began at 11 a.m. (EST) with welcoming comments by Dr. Shekim.  Sixteen researchers (participants list) were invited to participate in the workshop and offer their expertise in the discussion. There were five presentations organized into two major sessions, with discussion time after each session.

The first session started with a presentation from Dr. Fried-Oken, who gave an overview of the current relationship between the AAC and BCI fields. She began by reviewing recommendations from previous NIDCD workshops. Dr. Fried-Oken identified six challenges facing the fields. She then offered four charges to the BCI field from an AAC perspective.

Dr. Jane Huggins gave the second presentation, which focused on the engineering challenges for AAC and BCI. She reviewed seven challenges, some of which were:  performance metrics, brain signals, intra-subject variability, calibration, and integration of AAC-BCI.

Dr. Huggins’ presentation was followed by a presentation from Dr. Leigh Hochberg on neurosciences challenges. Dr. Hochberg began by pointing to the changing landscape among the neurosciences, neuro-engineering, neurology/neuro-surgery/physical medicine and AAC fields. He reviewed challenges for AAC, challenges for BCI, and challenges for both AAC and BCI.

The second session began with a presentation from Ms. Theresa Vaughan, who focused on issues relative to the adult population. The presentation outlined the three groups of interest: researchers, clinicians, and users, and stressed the importance of taking into consideration input from users. She then presented on the experience of the Wadsworth group to date.

Ms. Vaughan’s presentation was followed by a presentation from Dr. MaryAnn Romski on clinical issues relative to the pediatric population. She began with related research advances from the 1990s (e.g., cochlear implants) and moved to current practice (e.g., eye tracking AAC). Dr. Romski also outlined the two groups of pediatric users: those with conditions and those with acquired conditions. Dr. Romski’s presentation focused on BCI adaptations and considered potential uses, such as and integrating BCI use for intervention.

Discussion

Following the presentations, the group was asked to name and discuss the challenges in the path towards synergy between the AAC and BCI fields so that NIDCD-funded research can better serve individuals with SSPI. The following is a summary, as noted by Dr. Fried-Oken:

Defining the population of potential BCI users:

The BCI literature contains a wide range of descriptions of research participants. The field lacks a consensus regarding the target population for BCI technology. A clear, consistent description of this population would help researchers and developers understand the needs of their target users. It would be beneficial to describe the scope of different age groups with a wide range of disabilities, complications from motor impairments, and cognitive/linguistic impairments (both developmental and acquired conditions).

User-centered design:

The needs, abilities, limitations, and goals of people who may benefit from BCI technology are not always appreciated fully by researchers. The difficulties in expression experienced by people with SSPI naturally contribute to this. AAC clinician-researchers can assist with this. People with SSPI are seldom included in BCI research and development (R&D) teams, so they lack the opportunity to provide input on how BCI can be developed to best meet their needs. As one expert put it, this situation can lead to “researchers [who] don’t understand the needs of the target population and often provide ‘example’ applications that have no real applicability.”

The concepts of user-centered design, participatory action research, and patient-centered outcomes should be applied to ensure that BCIs will meet the needs of users. BCIs should be made available to users with a wide variety of physical, cognitive, and linguistic limitations and abilities.

Multidisciplinary collaboration:

BCI research frequently takes place in engineering labs, with investigators who have limited experience in communication sciences, AAC, or working with individuals with disabilities. Researchers and clinicians with expertise in these areas may see the value in BCI technology for people with SSPI, but lack the technical and engineering skills required to create it. These groups (and others, including neuroscientists, natural language processing experts, etc.) can all provide valuable contributions to BCI R&D, and can make the greatest impact on the field—and on the lives of BCI users—by working together. Unfortunately, multidisciplinary teams in this domain of research work are rare, and many research groups that would like to establish such teams have no easy way of connecting with experts in other fields.

Improving BCI technology:

Current BCI technology leaves considerable room for improvement in areas such as accuracy, reliability, convenience, and ease of use. BCI must be considered in the context of the larger field of assistive technology (AT); for some users, a stand-alone BCI may be appropriate, while others may use BCI to supplement or interface with other AT.

Planning for technology transfer and clinical implementation:

Numerous issues must be addressed before BCI technology becomes available to individuals with SSPI for independent home use. In addition to the technology improvements described above, BCI users will need access to well-informed prescribers and clinicians, training resources, and technical support services. Funding issues, such as health insurance reimbursement for BCI-based AAC technology, must also be considered.

Obstacles for BCI researchers:

BCI R&D groups applying for grant funding have encountered difficulty finding a review group that understands and recognizes the importance of this topic. The current funding environment and academic culture may discourage multidisciplinary collaboration and leave researchers with little time to do the work that needs to be done.

Reading List Recommended and Read by Workshop Panel

Review Papers

Research studies:

Noise standards/regulations:

Primary Research Papers

Animal studies:

Human Electrophysiology and Human Psychophysics:

Optional:

Mechanisms/Therapies:

Optional:

Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Avoid heavy lifting, sudden bending, and prolonged bed rest.
  • Use comfortable posture and gentle movement as tolerated.
  • Discuss physiotherapy, X-ray, or MRI only when clinically needed.

OTC medicine safety

  • For mild back pain, pain-relief medicine may be discussed with a doctor or pharmacist.
  • Avoid repeated painkiller use if you have kidney disease, stomach ulcer, uncontrolled blood pressure, or are taking blood thinners.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Back pain with leg weakness, numbness around private area, loss of urine/stool control, fever, cancer history, or major injury needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Doctor / qualified healthcare provider
Tests to discuss with doctor
  • Basic vital signs: temperature, pulse, blood pressure, oxygen level if needed
  • Relevant blood, urine, imaging, or specialist tests only after clinical assessment
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Care roadmap for: Alternative Communication and Brain-Computer Interface Synergy

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • Severe or rapidly worsening symptoms
  • Breathing difficulty, chest pain, fainting, confusion, severe weakness, major injury, or severe dehydration
Doctor / service to discuss: Qualified healthcare provider; specialist depends on symptoms and examination.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Do tests after clinical assessment. Avoid unnecessary tests, random antibiotics, or repeated medicines without diagnosis.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

Internal learning pathway

Explore related RX articles

Related guides from RX Harun are grouped to help readers move from overview to symptoms, tests, treatment, and safe next steps.

Rx Research
  1. Anti-Androgens Therapy DefinitionAnti-androgen therapy refers to medication taken by women to counteract the effect of male sex hormones such as testosterone on…
  2. Hatsune-miku-voice-text-to-speech DefinitionHatsune Miku also called Miku Hatsune and officially code-named CV01, is a Vocaloid software voicebank developed by Crypton Future Media and its official anthropomorphic mascot character, a…
  3. Translational Research in Hearing and Balance DefinitionAll individuals had been pre-assigned to one of four discussion groups focusing on differing areas of…
  4. Molecular Therapies for Auditory/Vestibular Disease Workshop DefinitionThe last decade of molecular and genetic? research has increased our understanding of basic processes and…
  5. Communication Disorders Workshops DefinitionThe Epidemiology of Communication Disorders Workshop was held March 29-30, 2005, in Bethesda, Maryland. The purpose…
  6. Tinnitus Research Workshop DefinitionThe NIDCD held a workshop to bring together key people currently doing clinical? and basic research…